Medical Oncologist
CION Cancer Clinics
Triple negative breast cancer: why testing criteria are broader | CION Cancer Clinics
Triple negative describes a breast tumour's receptor pattern, not its stage, and this specific pattern is more closely linked to an inherited fault than most other breast cancers. Because of that, genetic testing is recommended more broadly for triple negative disease than for breast cancer generally. This page explains why, what a result can change, and what it does not settle. At CION Cancer Clinics in Hyderabad, our oncologists review your family history with you and guide you to the right genetic counselling and testing.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why does triple negative breast cancer change the testing criteria?
- Why is this pattern linked to an inherited fault?
- What happens after a triple negative diagnosis?
- Terms that come with a triple negative diagnosis
- Receptor-positive breast cancer, versus triple negative
- Does triple negative always mean an inherited fault?
- What people get wrong about triple negative breast cancer
- Common questions about triple negative breast cancer and testing
A specific breast cancer type
Why does triple negative breast cancer change the testing criteria?
Triple negative breast cancer is a pattern seen on your pathology report, not a stage or a severity label. It means the tumour cells lack three particular receptors doctors usually check for. This specific pattern is more closely linked to an inherited fault than most other breast cancer types, which is why testing guidance for it is more relaxed than for breast cancer generally.
What "triple negative" is actually reporting
A breast tumour is normally tested for three things: two hormone receptors and one growth-signal receptor. When all three come back absent, the cancer is called triple negative. It behaves differently from receptor-positive breast cancer and is treated differently, and it shows up more often in people carrying a specific inherited fault.
Age still matters, but the bar is lower
Many testing guidelines now recommend genetic testing for triple negative breast cancer diagnosed at almost any adult age, rather than reserving it for younger women the way general breast cancer testing criteria often do.
"Triple negative" describes the tumour's receptor pattern. It is not a comment on how advanced the cancer is.The connection to genetics
Why is this pattern linked to an inherited fault?
The link is strong enough that a triple negative result alone is treated as a reason to test, in most guidelines used today.
One gene fault in particular
A large share of triple negative breast cancers occurring in people who carry a specific well-studied inherited fault are triple negative, far more than would be expected in the general population.
It can appear with no family history
Because a fault can arise for the first time in one person, triple negative breast cancer with an entirely unremarkable family history can still carry a meaningful chance of an inherited cause.
A result can guide treatment as well as risk
For some people with triple negative breast cancer, a confirmed inherited fault can open up specific treatment options alongside standard chemotherapy, decided jointly with your oncologist.
It matters for the rest of the family too
A confirmed fault found through your diagnosis can be tested for directly in sisters, daughters and other close relatives, rather than leaving them to rely on family history alone.
Not sure whether this applies to you?
Ask an oncologistWhat happens next
What happens after a triple negative diagnosis?
-
Pathology confirms the receptor pattern
This is part of standard testing done on every breast cancer diagnosis, not an extra step taken only in unusual cases.
-
Your oncologist notes the triple negative result
This is recorded alongside your age and family history when deciding whether a genetic referral is appropriate.
-
A genetic counselling referral is usually offered
For triple negative breast cancer, many centres offer this regardless of age, given how strong the link to an inherited fault can be.
-
A blood sample is tested alongside treatment planning
Testing can often be arranged quickly enough that a result is available before treatment decisions are finalised, though this varies by case.
-
The result is explained alongside your treatment plan
Your oncologist and genetic counsellor will discuss together what the result means for your treatment and for your relatives.
Words on your report
Terms that come with a triple negative diagnosis
- Hormone receptor
- A protein on a cancer cell that responds to hormones. Its presence or absence guides which treatments are likely to work.
- HER2
- A growth-signal receptor checked alongside the two hormone receptors. Triple negative means all three come back absent.
- Germline fault
- Present in every cell from birth, and inheritable, unlike a change found only inside the tumour.
- Somatic mutation
- A change found only in the tumour tissue, not inherited and not passed to children. This vertical covers inherited testing only.
- Panel testing
- Checking several genes at once from a single blood sample, rather than testing one gene at a time.
- Genetic counsellor
- The specialist who arranges the test and explains what a result means for your treatment and your family.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Receptor-positive breast cancer, versus triple negative
Receptor-positive breast cancer
Triple negative breast cancer
Genetic testing criteria often depend on age
Genetic testing is often offered regardless of age
Hormone-blocking treatment is usually an option
Treatment relies more heavily on chemotherapy and, sometimes, targeted options
Inherited fault explains a smaller share of cases
Inherited fault explains a larger share of cases
Family history carries more weight in the decision to test
The diagnosis itself often carries the most weight
Being straight with you
Does triple negative always mean an inherited fault?
No. Most people with triple negative breast cancer still test negative for every gene currently known to be linked to it. What sets this diagnosis apart is that the chance of finding a fault is high enough that testing is worthwhile for almost everyone with this result, not that a fault is expected in every case.
This is different from testing the tumour for treatment
Some tumour tests look for changes inside the cancer cells only, to guide which drugs are likely to help. That is a separate process from inherited genetic testing, and it lives with your oncology treatment team rather than with genetic counselling.
What this page cannot tell you
It cannot tell you whether your own triple negative diagnosis carries an inherited fault, or interpret a result you may already be holding. That is a conversation for the genetic counsellor working alongside your oncologist.
If you have triple negative breast cancer and have not been offered genetic counselling, ask your oncologist directly.Commonly believed
What people get wrong about triple negative breast cancer
"Triple negative means the cancer is more advanced."
Triple negative describes the receptor pattern of the tumour, not its stage. A triple negative cancer is staged the same way any other breast cancer is, based on its own size and spread.
"If it were genetic, it would run obviously in my family."
A fault can appear for the first time in one person. Triple negative breast cancer with no other family history can still carry a meaningful chance of an inherited cause.
"There's nothing genetic testing can add once treatment has already started."
For some people, a confirmed fault can still open up specific treatment options during active treatment, not only affect future decisions.
"Testing the tumour and genetic testing are the same thing."
Tumour testing looks at changes inside the cancer cells only, to guide drug choice. Genetic testing looks at every cell in your body and tells your family whether a fault can be inherited.
Questions we are asked
Common questions about triple negative breast cancer and testing
Do I need genetic testing if my triple negative cancer was diagnosed later in life?
Many current guidelines recommend testing for triple negative breast cancer at almost any adult age, not only for younger women. Ask your oncologist whether this applies to your specific case.
Will a genetic result change my chemotherapy plan?
Sometimes. For some people, a confirmed inherited fault can open up specific treatment options alongside standard chemotherapy. Your oncologist and genetic counsellor will discuss this with you directly.
Is this the same test as the one done on my tumour tissue?
No. Tumour testing looks for changes inside the cancer cells only, to guide drug choice. Genetic testing looks at a blood sample and checks every cell in your body for an inherited fault.
Can triple negative breast cancer happen without any faulty gene?
Yes. Most people with this diagnosis still test negative on every gene currently linked to it. Testing is worth doing because the odds are higher than usual, not because a fault is expected every time.
Should my sisters be tested even before I get my result?
Usually it is better to wait. Testing you first tells the counsellor exactly which fault, if any, to look for in your sisters, rather than testing them broadly and unnecessarily.
How long does the genetic test take?
It varies by laboratory, but results are often available within a few weeks, and centres try to align this with treatment planning where possible.
What if I've already finished treatment — is it too late to test?
No. Testing remains valuable after treatment, both for your own ongoing surveillance and for informing relatives, so it is worth asking about even years later.
Where do I start?
Ask your treating oncologist for a referral to genetic counselling. If you are unsure, call the CION helpline and describe your diagnosis.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Triple-Negative Breast Cancer
- GeneReviews (NCBI) — BRCA1/2 Hereditary Breast and Ovarian Cancer
- NCCN — NCCN Guidelines for Patients: Genetic Testing for Hereditary Cancer
- Cancer Research UK — Inherited cancer genes and increased cancer risk
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Male breast cancer and genetic testingAnother breast cancer pattern that qualifies for testing on its ownOvarian cancer: why everyone is offered testingThe same gene fault raises risk here tooTesting criteria explained without the jargonSee the full list of what counts, in plain languageCancer at a young age: when it points to a geneA related standalone criterion
Talk to us
Diagnosed with triple negative breast cancer?
Tell us your age at diagnosis and we will tell you honestly whether a genetic referral is worth making alongside your treatment. One helpline serves every CION centre.